Related references
Note: Only part of the references are listed.Xpert® MTB/RIF Shortens Airborne Isolation for Hospitalized Patients with Presumptive Tuberculosis in the United States
Christopher K. Lippincott et al.
CLINICAL INFECTIOUS DISEASES (2014)
False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results
T. H. Boyles et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Pyrosequencing for Rapid Detection of Extensively Drug-Resistant Mycobacterium tuberculosis in Clinical Isolates and Clinical Specimens
S. -Y. Grace Lin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Antituberculosis Drug Resistance Acquired During Treatment: An Analysis of Cases Reported in California, 1994-2006
Travis C. Porco et al.
CLINICAL INFECTIOUS DISEASES (2013)
Diabetes is associated with drug-resistant tuberculosis in Eastern Taiwan
A-H. Hsu et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment
Sven O. Friedrich et al.
LANCET RESPIRATORY MEDICINE (2013)
False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications
A. Van Rie et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
Danica Helb et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology
Pontus Jureen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia
M Ruddy et al.
THORAX (2005)
Share Paper
